Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors

J Med Chem. 2007 Mar 22;50(6):1280-7. doi: 10.1021/jm061381f. Epub 2007 Feb 15.

Abstract

The Ras/Raf/MEK/ERK signal transduction is a key oncogenic pathway implicated in a variety of human cancers. We have identified a novel series of pyrazolylpyrroles as inhibitors of ERK. Aided by the discovery of two distinct binding modes for the pyrazolylpyrrole scaffold, structure-guided optimization culminated in the discovery of 6p, a potent and selective inhibitor of ERK.

MeSH terms

  • Binding Sites
  • Crystallography, X-Ray
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors*
  • Mitogen-Activated Protein Kinase 1 / chemistry
  • Mitogen-Activated Protein Kinase 3 / antagonists & inhibitors*
  • Mitogen-Activated Protein Kinase 3 / chemistry*
  • Models, Molecular
  • Molecular Structure
  • Protein Binding
  • Pyrazoles / chemical synthesis*
  • Pyrazoles / chemistry
  • Pyrroles / chemical synthesis*
  • Pyrroles / chemistry
  • Quantitative Structure-Activity Relationship*
  • Stereoisomerism

Substances

  • N-(1-(3-chloro-4-fluorophenyl)-2-hydroxyethyl)-4-(4-(3-chlorophenyl)-1H-pyrazol-3-yl)-1H-pyrrole-2-carboxamide
  • Pyrazoles
  • Pyrroles
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3

Associated data

  • PDB/2OJG
  • PDB/2OJI
  • PDB/2OJJ
  • PDB/2OJL
  • PDB/ERK2
  • PDB/JNK3